Preclinical Safety Assessment of Ad[I/PPT-E1A], a Novel Oncolytic Adenovirus for Prostate Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Preclinical Safety Assessment of Ad[I/PPT-E1A], a Novel Oncolytic Adenovirus for Prostate Cancer

Published:2014-03 Issue:1 Volume:25 Page:7-15
ISSN:2324-8637
Container-title:Human Gene Therapy Clinical Development
language:en
Short-container-title:Human Gene Therapy Clinical Development

Author:

Schenk Ellen¹,Essand Magnus²,Kraaij Robert³,Adamson Rachel⁴,Maitland Norman J.⁴,Bangma Chris H.¹

Affiliation:

1. Department of Urology, Erasmus MC, 3000 CA Rotterdam, The Netherlands.

2. Rudbeck Laboratory, Department of Immunology, Genetics, and Pathology, Uppsala University, SE-75185 Uppsala, Sweden.

3. Department of Internal Medicine, Erasmus MC, 3000 CA Rotterdam, The Netherlands.

4. YCR Cancer Research Unit, Department of Biology, University of York, Heslington, York YO10 5DD, United Kingdom.

Publisher

Mary Ann Liebert Inc

Subject

Genetics (clinical)

Link

http://www.liebertpub.com/doi/pdf/10.1089/humc.2013.181

Reference26 articles.

1. In Vitro Primary Cell Culture as a Physiologically Relevant Method for Preclinical Testing of Human Oncolytic Adenovirus

2. Minimal hepatic toxicity of Onyx-015: spatial restriction of coxsackie-adenoviral receptor in normal liver

3. Phase I Study of Noninvasive Imaging of Adenovirus-mediated Gene Expression in the Human Prostate

4. Human erythrocytes bind and inactivate type 5 adenovirus by presenting Coxsackie virus-adenovirus receptor and complement receptor 1

5. Characterization of the Androgen-Regulated Prostate-Specific T Cell Receptor γ-Chain Alternate Reading Frame Protein (TARP) Promoter

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Perspective Chapter: Liposome Mediated Delivery of Immunotherapeutics for Cancer;Liposomes - Recent Advances, New Perspectives and Applications;2023-02-08

2. Targeting circulating monocytes with CCL2-loaded liposomes armed with an oncolytic adenovirus;Nanomedicine: Nanotechnology, Biology and Medicine;2022-02

3. Glioblastoma Therapy: Rationale for a Mesenchymal Stem Cell-based Vehicle to Carry Recombinant Viruses;Stem Cell Reviews and Reports;2021-07-28

4. Development of a New Hyaluronic Acid Based Redox-Responsive Nanohydrogel for the Encapsulation of Oncolytic Viruses for Cancer Immunotherapy;Nanomaterials;2021-01-08

5. Delivery and Biosafety of Oncolytic Virotherapy;Frontiers in Oncology;2020-04-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3